Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT02569502
Eligibility Criteria:
Inclusion Criteria:
* Adult or adolescent patients greater than (\>)16 years of age
* HIV-1 infection
* CD4 count less than (\<)350/cubic millimeters (mm\^3)
* HIV RNA viral load \>10,000 copies per milliliter (copies/mL) while on highly active antiretroviral therapy (HAART)
* Documented resistance, treatment-limiting toxicity, and/or \>=6 months' prior experience with each of 3 currently available classes of antiretroviral drugs.
Exclusion Criteria:
* Women who are pregnant or breastfeeding;
* Patients unable to self-inject;
* Active, untreated opportunistic infection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT02569502
Study Brief:
Protocol Section:
NCT02569502